Rapport Therapeutics | 10-Q:季度报表
Rapport Therapeutics | 8-K:重大事件
Rapport Therapeutics | SEC STAFF LETTER:其他
Rapport Therapeutics | SC 13G:超过5%持股股东披露文件-FMR LLC(13.624%),Abigail P. Johnson(13.624%)
Rapport Therapeutics | 4:持股变动声明-董事 HEALY JAMES
Rapport Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-THE GOLDMAN SACHS GROUP, INC.(3.5 %),GOLDMAN SACHS & CO. LLC(3.5 %)等
Rapport Therapeutics | SC 13G:超过5%持股股东披露文件-THE GOLDMAN SACHS GROUP, INC.(7.5 %),GOLDMAN SACHS & CO. LLC(7.5 %)等
Rapport Therapeutics | SC 13G:超过5%持股股东披露文件-Cormorant Asset Management, LP(8.04%),Bihua Chen(8.04%)等
Rapport Therapeutics | SC 13D:超过5%持股股东披露文件-Dr. James I. Healy (“Healy”)(5.5%),Sofinnova Venture Partners XI, L.P. (“SVP XI”)(5.3%)等
Rapport Therapeutics | 4:持股变动声明-股东 ARCH Venture Partners XII, LLC
Rapport Therapeutics | 4:持股变动声明-高管 Galer Bradley S.
Rapport Therapeutics | 4:持股变动声明-高管 Gault Cheryl
Rapport Therapeutics | 4:持股变动声明-高管 Bredt David
Rapport Therapeutics | 4:持股变动声明-高管 Yeleswaram Krishnaswamy
Rapport Therapeutics | 4:持股变动声明-股东 Third Rock Ventures V, L.P.
Rapport Therapeutics | 4:持股变动声明-高管 Ceesay Abraham
Rapport Therapeutics | 4:持股变动声明-董事 HEALY JAMES
Rapport Therapeutics | 4:持股变动声明-高管 Ignelzi Troy A.
Rapport Therapeutics | 8-K:重大事件
Rapport Therapeutics | S-8:员工福利计划证券登记
暂无数据